{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:28:04Z","timestamp":1761596884137},"reference-count":30,"publisher":"American Physiological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:p> Osteoporosis is a disease that is strongly genetically determined. Aromatase converts androgens to estradiol in postmenopausal women, therefore polymorphisms of the gene for this enzyme may be associated with bone mass and fracture. We investigated the association of the TTTA microsatellite polymorphism in intron 4 of the aromatase (CYP19) gene with bone mineral density (BMD) and fracture in 1,257 women aged 70 yr and greater. The data obtained were stratified based on the presence or absence of a [TTTA]n of 7 (A2), determined from a preliminary analysis of hip dual-energy X-ray absorptiometry BMD, which was present in 27% of the population. The presence of an A2 allele was associated with a higher free estradiol index (0.52 \u00b1 0.49, P = 0.049) compared with the absence of an A2 allele (0.47 \u00b1 0.45); higher BMD at all sites of the hip (3.4% total hip, 2.3% femoral neck, 3.6% intertrochanter, 4.1% trochanter) and the lumbar spine (12.7%); higher values for the calcaneal quantitative ultrasound parameters broadband ultrasound (1.3%), speed of sound (0.4%), and stiffness (3.7%); and higher peripheral quantitative computed tomography measures for total (3.4%), trabecular (3.3%), and cortical BMD (3.3%) and the derived stress strain index (SSI) parameters SSI polar (6.4%) and SSI \u00d7 (6.8%) values. A lower deoxypryridinoline creatinine ratio was observed in subjects with an A2 allele (30.3 \u00b1 10.4 vs. 27.1 \u00b1 9.1, P = 0.03). The A2 allele was associated with a lower prevalence of vertebral fracture in subjects who were osteoporotic (odds ratio 0.27, confidence interval 0.09\u20130.79). Therefore, a common polymorphism of the aromatase gene, perhaps in linkage disequilibrium with a functionally significant CYP19 polymorphism, is associated with bone structure and bone turnover, either by local effects or by effects on circulating bioactive estrogen. <\/jats:p>","DOI":"10.1152\/ajpendo.00550.2004","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T02:58:44Z","timestamp":1103684324000},"page":"E989-E995","source":"Crossref","is-referenced-by-count":41,"title":["Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women"],"prefix":"10.1152","volume":"288","author":[{"given":"I. M.","family":"Dick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. L.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Augat P, Reeb H, and Claes LE. Prediction of fracture load at different skeletal sites by geometric properties of the cortical shell. J Bone Miner Res 11: 1356\u20131363, 1996.","DOI":"10.1002\/jbmr.5650110921"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.2.347"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2002.50012.x"},{"key":"R4","unstructured":"Christian JC, Yu PL, Slemenda CW, and Johnston CC. Heritability of bone mass: a longitudinal study in aging male twins. Am J Hum Genet 44: 429\u2013433, 1989."},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1674-6"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031342"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20000715)87:2<204::AID-IJC8>3.0.CO;2-3"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.2.189"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1385\/JCD:3:4:359"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.1.172"},{"key":"R11","unstructured":"Ireland P, Jolley D, Giles G, O'Dea K, Powles J, Ritishauser I, Wahlqvist ML, and Williams J. Development of the Melbourne FFQ: a food frequency questionaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pacific J Clin Nutr 3: 19\u201331, 1994."},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623782"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-4-808"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650050409"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203425"},{"key":"R16","unstructured":"Masi L, Becherini L, Gennari L, Amedei A, Colli E, Falchetti A, Farci M, Silvestri S, Gonnelli S, and Brandi ML. Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. J Clin Endocrinol Metab 86: 2263\u20132269, 2001."},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623275"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Polymeropoulos MH, Xiao H, Rath DS, and Merril CR. Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res 19: 195, 1991.","DOI":"10.1093\/nar\/19.1.195"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.4.2234"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, Prince RL, Stewart G, Stuckey B, Will RK, Retallack RW, Price RI, and Ward L. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res 11: 1176\u20131184, 1996.","DOI":"10.1002\/jbmr.5650110817"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198903023200903"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1995.tb01608.x"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690071"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.11.8547"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030164"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Sourdaine P, Parker MG, Telford J, and Miller WR. Analysis of the aromatase cytochrome P450 gene in human breast cancers. J Mol Endocrinol 13: 331\u2013337, 1994.","DOI":"10.1677\/jme.0.0130331"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(88)90227-6"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00149-1"},{"key":"R29","unstructured":"Tofteng CL, Kindmark A, Brandstrom H, Abrahamsen B, Petersen S, Stiger F, Stilgren LS, Jensen JE, Vestergaard P, Langdahl BL, and Mosekilde L. Polymorphisms in the CYP19 and AR genes\u2013relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study. Calcif Tissue Int 74: 25\u201334, 2004."},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1500699"}],"container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpendo.00550.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T18:34:23Z","timestamp":1567967663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpendo.00550.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1152\/ajpendo.00550.2004"],"URL":"https:\/\/doi.org\/10.1152\/ajpendo.00550.2004","relation":{},"ISSN":["0193-1849","1522-1555"],"issn-type":[{"value":"0193-1849","type":"print"},{"value":"1522-1555","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}